ItamarTM Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss.

Itamar Medical (TASE: ITMR), a company which develops, markets and sells non-invasive medical devices for the diagnosis and treatment of sleep apnea, with a focus on the cardiology market, today reported record revenues for the fourth quarter and full year ended December 31, 2017. As a result of a successful change in its business model and the increase in sales of probes and tests, the Company achieved continued and rapid revenue growth from its WatchPAT™ device (excluding revenues from the positive airway pressure, or PAP device) of 24% and 20%, respectively, in the year and quarter ended December 31, 2017.